0001728411-18-000001.txt : 20180118 0001728411-18-000001.hdr.sgml : 20180118 20180117191024 ACCESSION NUMBER: 0001728411-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180118 DATE AS OF CHANGE: 20180117 EFFECTIVENESS DATE: 20180118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DMC Biotechnologies, Inc. CENTRAL INDEX KEY: 0001728411 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-303493 FILM NUMBER: 18532612 BUSINESS ADDRESS: STREET 1: 5333 EUCLID AVENUE CITY: BOULDER STATE: CO ZIP: 80303 BUSINESS PHONE: (303) 210-2829 MAIL ADDRESS: STREET 1: 5333 EUCLID AVENUE CITY: BOULDER STATE: CO ZIP: 80303 D 1 primary_doc.xml X0708 D LIVE 0001728411 DMC Biotechnologies, Inc. 5333 EUCLID AVENUE BOULDER CO COLORADO 80303 (303) 210-2829 DELAWARE None None Corporation true 2017 Matthew L. Lipscomb c/o DMC Biotechnologies, Inc. 5333 Euclid Avenue Boulder CO COLORADO 80303 Executive Officer Director Michael D. Lynch c/o DMC Biotechnologies, Inc. 5333 Euclid Avenue Boulder CO COLORADO 80303 Director Rob van der Meij c/o DMC Biotechnologies, Inc. 5333 Euclid Avenue Boulder CO COLORADO 80303 Director Biotechnology Decline to Disclose 06b false 2018-01-04 false true false 0 2499999 1166666 1333333 Offer and Sale of Series Seed Preferred Stock (and the shares issuable thereunder) false 1 0 0 0 false DMC Biotechnologies, Inc. Matthew L. Lipscomb Matthew L. Lipscomb Chief Executive Officer 2018-01-11